featured
5-Fluorouracil/Leucovorin With Oxaliplatin Not Effective as Second-Line Treatment for Advanced Pancreatic Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
PANCREOX: A Randomized Phase III Study of 5-Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
J. Clin. Oncol 2016 Sep 12;[EPub Ahead of Print], S Gill, YJ Ko, C Cripps, A Beaudoin, S Dhesy-Thind, M Zulfiqar, P Zalewski, T Do, P Cano, WY Lam, S Dowden, H Grassin, J Stewart, M MooreFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.